Our recent efforts to develop near real-time AI have been featured in this NVIDIA Blog post "The Fastest Path: Healthcare Startup Uses AI to Analyze Cancer Cells in the Operating Room."
#ArtificialIntelligence#invenio#PatientCare#Cancer
https://t.co/MAeeYkd75H
The first Austrian Radio Station (ORF1) will feature Dr. Georg Widhalm from Universitätsklinikum AKH Wien using the NIO Laser Imaging System with the NIO Glioma Reveal artificial intelligence image analysis module during a glioma resection. Tune in at 20:15h (GMT+2) on May 3!
Invenio Imaging, Inc., a leader in intraoperative fresh tissue imaging and artificial intelligence, today announced that it has entered into a research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson. https://t.co/z9Aw5WtOzF
We look forward to seeing you at the presentation by by Dr. Georg Widhalm, Dr. Lisa Wadiura, and Dr. David Hersh about "Personalized Medicine in the Treatment of Neuro-Oncology and Neurosurgical Disease" at the upcoming JNSPG Journal Club on December 20 from 9:00 - 10:00 a.m. ET.
We're celebrating another milestone: 3000 NIO cases!
Thank you to everyone that has been part of this journey including all our partners, surgeons, pathologists, interventional pioneers, clinical support team, investors and alumni.
#neurosurgery#neuropathology#NIOImagingSystem
We're #hiring multiple #clinicalresearchspecialist for an upcoming clinical trial in New York City, Houston, and Chapel Hill.
Please visit the Careers page on our website for more information:
https://t.co/rfnTp1OZ1e
Congratulations to the @NYULangonePCCSM team for their 500th case using the NIO Imaging System! Thank you for being pioneers and we look forward to our continued collaboration.
Drs. @SamaanRafeq, Jamie Bessich, @YanglinGuo, Luis Angel, @VivekMurthy10, Yu Htwe, Daniel da Costa
On #GBMDay we want to help raise awareness about this form of brain cancer as we recommit to improving the care of cancer patients with rapid onsite fresh tissue imaging and artificial intelligence. You can take action with @NBTStweets#glioblastoma#braintumor#braincancer
#GBMDay is one week away! On July 20, take action and raise awareness to shine a light on the most common, complex, treatment-resistant, and deadliest type of brain cancer: https://t.co/r52Qian19r